Nuzenio

Biocon Launches Eylea

Biocon Launches Eylea news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

event 11 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Biocon announces commercial launch of Yesafili in USA - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 18:16:32 GMTEyePoint Completes Enrollment in Two Phase 3 Trials Evaluating Duravyu for DME - Eyewire+Eyewire+ · Wed, 05 Aug 2026 18:46:05 GMTBiocon launches interchangeable biosimilar Yesafili for retinal diseases in US market - Indian Pharma PostIndian Pharma Post · Tue, 04 Aug 2026 06:21:06 GMTYesafili, an Eylea biosimilar, launches with a price of $1,445 - Managed Healthcare ExecutiveManaged Healthcare Executive · Mon, 03 Aug 2026 18:46:35 GMTBiocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg - Business WireBusiness Wire · Mon, 03 Aug 2026 11:05:00 GMTBiocon launches Yesafili biosimilar to Regeneron’s Eylea in US - BitgetBitget · Mon, 03 Aug 2026 07:00:00 GMTBiocon Launches Yesafili in US, Stock Touches Day High of Rs 429 - EquitypanditEquitypandit · Mon, 03 Aug 2026 05:37:13 GMTBiocon US launch: Yesafili biosimilar to Eylea enters the market - Business UpturnBusiness Upturn · Mon, 03 Aug 2026 03:30:34 GMT

Timeline

Fri, 07 Aug 2026 18:16:32 GMTBiocon announces commercial launch of Yesafili in USA - The Pharma Letter
Wed, 05 Aug 2026 18:46:05 GMTEyePoint Completes Enrollment in Two Phase 3 Trials Evaluating Duravyu for DME - Eyewire+
Tue, 04 Aug 2026 06:21:06 GMTBiocon launches interchangeable biosimilar Yesafili for retinal diseases in US market - Indian Pharma Post
Mon, 03 Aug 2026 18:46:35 GMTYesafili, an Eylea biosimilar, launches with a price of $1,445 - Managed Healthcare Executive
Mon, 03 Aug 2026 11:05:00 GMTBiocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg - Business Wire
Mon, 03 Aug 2026 07:00:00 GMTBiocon launches Yesafili biosimilar to Regeneron’s Eylea in US - Bitget

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Biocon Launches Eylea.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.